IN VITRO ASSESSMENT OF THE ANTIMICROBIAL PROPERTIES OF TRANEXAMIC ACID: IMPLICATIONS FOR INTRAOPERATIVE PROPHYLAXIS OF IMPLANT-ASSOCIATED INFECTIONS IN ORTHOPAEDIC SURGERY
(2025)
Presentation / Conference Contribution
Kaisi, K. A., Trampuz, A., Okoro, T., & Karbysheva, S. (2025, March). IN VITRO ASSESSMENT OF THE ANTIMICROBIAL PROPERTIES OF TRANEXAMIC ACID: IMPLICATIONS FOR INTRAOPERATIVE PROPHYLAXIS OF IMPLANT-ASSOCIATED INFECTIONS IN ORTHOPAEDIC SURGERY. Presented at The British Hip Society (BHS) Meeting 2025, Harrogate, England
Tranexamic Acid (TXA) is a potent antifibrinolytic agent widely used to reduce perioperative blood loss and transfusion in arthroplasty surgery. It effectively conserves blood without increasing the risk of thrombosis. TXA may lower infection risk po... Read More about IN VITRO ASSESSMENT OF THE ANTIMICROBIAL PROPERTIES OF TRANEXAMIC ACID: IMPLICATIONS FOR INTRAOPERATIVE PROPHYLAXIS OF IMPLANT-ASSOCIATED INFECTIONS IN ORTHOPAEDIC SURGERY.